Living definition
What is Atacicept (Trutakna)?
Vaccines & Immunotherapy Bio, Health & Neuro
- As of
- 2026-10-04
- Revision
- 2026-10-06.1
- Method
- v1.4.0
Definition
The term, in context
AI-assisted draft · approved dataset
Atacicept (Trutakna) is a fusion-protein therapeutic that blocks the B-cell signalling factors BAFF and APRIL, developed for IgA nephropathy, an immune-mediated kidney disease.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-10-04, verified readiness is 55 (claimed 65, reported 55, gap 10) — Critical evidence strength; current signals suggest Clinically usable within its approved adult IgAN proteinuria indication; long-term kidney-protection claims remain conditional.
The readiness fact belongs to the canonical Readiness Verdict for Atacicept (Trutakna).
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06